Getting Ready For The Windsor Framework: Ensuring Continuity Of UK Medicines Supply Beyond 1 January 2025
There are increased complexities associated with potential regulatory divergence between the UK and the EU when the Medicines and Healthcare products Regulatory Agency takes over responsibility for UK-wide new drug approvals from January 2025, writes the ABPI's Rick Greville.